Cancer Clinical Trial Matching Improved by Computer Platform
The platform brought about roughly one in every five consents to join a precision medicine trial and also cut the time for patient enrollment by more than 20%.
Harry Klein Michael Hassett Ethan Cerami Researchers At Dana Farber Cancer Institute Institute Knowledge Systems Dana Farber Cancer Institute
Source: insideprecisionmedicine.com